You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 70 No. 4, April 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reinforcement of Fresh Autogenous Venografts to Aorta

Experimental Study with Polyvinyl Formalinized (Ivalon) Sponge

J D MORTENSEN, M.D.; JESSE E. EDWARDS, M.D.; JOHN H. GRINDLAY, M.D.; JOHN W. KIRKLIN, M.D.

AMA Arch Surg. 1955;70(4):545-554.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Successful replacement of segments of major arteries or of the aorta with preserved arterial homografts has given new impetus to the development of vascular surgery. In addition to extending the indications for resection of segments of arteries or of the aorta, successes with homografts have stimulated efforts to develop other methods for replacing the resected vessels.

Utilization of a segment of fresh autogenous vein as a graft to replace a resected segment of artery has certain advantages over the use of preserved arterial homografts. First, the use of a fresh autogenous venograft obviates the necessity of an arterial bank, which under many circumstances is difficult or impractical to maintain. Second, the fresh autogenous venograft is reported to "take," remain viable, and grow in its new position without being replaced by the recipient's tissues. These more biologically acceptable autografts have thus been considered less likely to undergo degenerative changes and might . . . [Full Text PDF of this Article]


Author Affiliations

Rochester, Minn.

Fellow in Surgery, Mayo Foundation (Dr. Mortensen). From the Section of Pathologic Anatomy (Dr. Edwards); Section of Surgical Research (Dr. Grindlay), and Section of Surgery (Dr. Kirklin), Mayo Clinic and Mayo Foundation.


Footnotes

The Mayo Foundation is a part of the Graduate School of the University of Minnesota.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.